Avita Medical Buy Hold or Sell Recommendation

AVMXY -- USA Stock  

USD 1.41  0.06  4.44%

Assuming 30 trading days horizon, and your above average risk tolerance our recommendation regarding Avita Medical Limited is 'Strong Sell'. Macroaxis provides Avita Medical buy hold or sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding AVMXY positions. The advice algorithm takes into account all of Avita Medical Limited available fundamental, technical, and predictive indicators you will find on this site. The advice is provided from AVMXY buy-and-hold prospective. Check also Avita Medical Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for muliple equity instruments please use Instant Ratings tool.

Time Horizon

Risk Tolerance

Symbol
Execute Advice
Sell Avita MedicalBuy Avita Medical
Strong Sell

Volatility

Hype Condition

Current Valuation

Odds of Distress

Economic Sensitivity

Analyst Consensus

For the selected time horizon Avita Medical Limited has a mean deviation of 2.42, semi deviation of 2.79, standard deviation of 3.13, variance of 9.78, downside variance of 9.42 and semi variance of 7.8
We provide buy or sell advice to complement the prevailing expert consensus on Avita Medical Limited. Our dynamic recommendation engine makes use of multi - dimensional algorithm to analyze the company potential to grow using all technical and fundamental data available at the time. To make sure Avita Medical is not overpriced, please confirm all Avita Medical Limited fundamentals including its Price to Sales, Cash per Share, Beta, as well as the relationship between EBITDA and Cash Flow from Operations . Please also double-check Avita Medical Limited Price to Sales to validate your buy or sell decision is consistent with all fundamental data available and that the company can sustain itself in the current economic cycle.

Avita Medical Returns Distribution Density

Mean Return0.046536Value At Risk5.56
Potential Upside3.45Standard Deviation3.13
 Return Density 
      Distribution 

Avita Medical Greeks

α
Alpha over DOW
=0.004829
β
Beta against DOW=0.34
σ
Overall volatility
=3.13
Ir
Information ratio =0.02

Avita Medical Volatility Alert

Avita Medical Limited shows above average downside volatility of 3.07 for selected time horizon. We advise investors to further inspect Avita Medical Limited to make sure all market timing and asset allocation strategies are consistent with estimation about Avita Medical future alpha.
    
 Better Than Average     
    
 Worse Than Average Compare Avita Medical to competition

Avita Medical Fundamental Vs Peers

FundamentalsAvita MedicalPeer Average
Return On Equity(111.87) % (15.17) %
Return On Asset(67.44) % (15.64) %
Current Valuation60.16 M152.14 B
Shares Outstanding1.05 B1.43 B
Price to Earning3.36 times40.69 times
Price to Book7.45 times14.44 times
Price to Sales98.76 times17.81 times
Revenue1.07 M9.85 B
Gross Profit675 K21.75 B
EBITDA(11.19 M)1.41 B
Net Income(10.49 M)517.71 M
Cash and Equivalents8.7 M3.89 B
Cash per Share0.17 times5.17 times
Current Ratio8.08 times3.30 times
Book Value Per Share0.20 times13.64 times
Cash Flow from Operations(8.53 M)1.25 B
Earnings Per Share0.26 times2.30 times
Number of Employees3710.67 K
Beta0.270.34
Market Capitalization105.64 M29.78 B
Total Asset6.41 M126.86 B
Retained Earnings(90.18 M)38.24 B
Working Capital5.03 M3.58 B
Current Asset6.33 M36.8 B
Current Liabilities1.3 M33.34 B
Z Score-22.9708.73

Avita Medical Alerts

Trading Alerts and Improvement Suggestions

Avita Medical may become a speculative penny stock
Avita Medical has very high historical volatility over the last 30 days
Avita Medical has high likelihood to experience some financial distress in the next 2 years
The company reported revenue of 1.07 M. Net Loss for the year was (10.49 M) with profit before overhead, payroll, taxes, and interest of 675 K.
AVITA MEDICAL has accumulated about 8.7 M in cash with (8.53 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.17.
Latest headline from markets.businessinsider.com: The skin graft market is estimated to account for US 1371.9 Mn by the end of 2025, and growing at a CAGR of 7.6 ...
Check also Avita Medical Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for muliple equity instruments please use Instant Ratings tool. Please also try Fundamentals Matrix module to view fundamentals matrix and analyze how accounts are interrelated and interconnected with each other.
Search macroaxis.com